Bioinformatics company M2GEN is known for its constant push to further oncology research discoveries through analytics and data. It recently announced an expansion of its executive team, appointing two new members: May Yoon has joined as chief people officer and Daniel Elgort, Ph.D., has been appointed chief data and analytics officer. These appointments promise to expand the company’s capabilities to provide differentiated analytics solutions for oncology research.
May Yoon takes her role with 15 years of human capital management and capability experience. She has previously worked as chief people officer at biometric identity company Clear, and IT firm Agio. Yoon utilized both jobs as an opportunity to oversee functional creation and delivery of end-to-end people strategies. She earned her baccalaureate degrees from Wellesley College, studying international relations and psychology, and a Master of Science in management and strategy from the London School of Economics.
M2GEN CEO Jim Gabriele expressed enthusiasm about Yoon’s addition to the team: “We are very excited to welcome May to the M2GEN executive leadership team. M2GEN is in the process of transforming its organization and capabilities, and we look forward to drawing on May’s talent development experience in technology-driven companies to drive patient impact and growth in the years to come.”
Daniel Elgorth, Ph.D., has worked as chief scientific officer at Cover Health. In this position he was able to create an individual healthcare data platform to collect radiological and pathology tissue data, linking it to clinical data. He was also in charge of constructing analytic services intended to improve patient quality of care. He has baccalaureates in biomedical engineering and computer science from Johns Hopkins University, as well as a Master of Science and Ph.D. in biomedical engineering from Case Western Reserve University.
Gabriele said, “We are pleased to welcome Dan to the M2GEN executive leadership team. As both a Fortune 100 leader and entrepreneur, Dan has spent his entire career at the intersection of healthcare, technology, and data science delivering unique digital products and services that meaningfully impact patient outcomes. Dan’s experience will be invaluable as we continue to scale and enhance our data and analytics solutions.”
Read the full article here.